Umbilical cord derived-mesenchymal stromal cells (Universidad de los Andes, Chile)

N/A

Report date: 2023/03/03 20:00:36

Base Information

Drug NameUmbilical cord derived-mesenchymal stromal cells (Universidad de los Andes, Chile)

Drug Alias Name脐带间充质基质细胞-University of the Andes

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsOsteoarthritis, Knee

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryChile

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of The Andes

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of The Andes, Chile

Inactive CompaniesN/A

Active IndicationsOsteoarthritis, Knee

Inactive IndicationsN/A

Other Information

ATC CodeN/A